Table 1.

A summary of reports on clinical and histologic features and oncologic outcomes of STUMP patients relapsed with leiomyosarcoma.

Reference			Histologic feature
	Age	Mass size (cm)	Surgery	Cellularity	Atypia	MI	Necrosis	Subtype	Recurrence	Treatment	Outcome
H. Sahin et al (Şahin et al.,)	52	20	Myomectomy	high	mild	6	present	SMT-LMP	LMS	Debulking + CTx	DOD
H.I. Ha et al (Ha et al., 2018)	49	6	Hysterectomy	high	mild	0–3	absent	N/A	LMS	Debulking + CTx	N/A
Ip PP et al. (Ip et al., 2009)	50	5	Hysterectomy	moderate	severe	4	infarct	AL-LE	LMS	Debulking + CTx	AAR
Ip PP et al. (Ip et al., 2009)	39	5.8	Hysterectomy	high	severe	5	infarct	AL-LE	LMS	Debulking + CTx	AAR
Basaran et al (Basaran et al., 2018)	52	N/A	Hysterectomy	mild	mild	2–5	present	SMT-LMP	LMS	Debulking + CTx	DOD
Basaran et al (Basaran et al., 2018)	51	9	Hysterectomy	mild	mild	< 2	present	SMT-LMP	LMS	Debulking + CTx	AAR
Basaran et al (Basaran et al., 2018)	38	N/A	Myomectomy	moderate	none	2–5	present	SMT-LMP	LMS	Hysterectomy	AAR
A.Shapiro et al (Shapiro et al., 2004)	46	4	Hysterectomy	N/A	severe	15	absent	AL-LE	LMS	Mass excision	DOD
G.Sanchez et al (García-Sánchez et al., 2019)	71	16	Hysterectomy	high	moderate	0–1	present	N/A	LMS	Mass excision	AAR

Abbreviations: SMT-LMP, smooth muscle tumors of low malignant potential; LMS, leiomyosarcoma; CTx, chemotherapy; DOD, dying of disease; AAR, alive after recurrence; AL-LE, atypical leiomyoma but limited experience; N/A, non-available.